Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

FDA awarded record number of review designations to CRISPR drugs in 2023, reveals GlobalData

In late 2023, Vertex Pharmaceuticals and CRISPR Therapeutics made history by gaining the first FDA approval for a CRISPR-based drug, exagamglogene autotemcel (Casgevy) for the treatment of sickle cell disease with vaso-occlusive crisis. This historic achievement coincided with a record number of 14 review designations awarded by the FDA to CRISPR-based therapies in 2023, according […]
Read more

Functional snacking will reshape APAC food industry, says GlobalData

Changing dietary preferences and increasing health awareness are the key factors propelling the demand for functional food products in Asia-Pacific (APAC). Meanwhile, the growing awareness of lifestyle-related diseases and the importance of preventive healthcare are also encouraging consumers to seek out foods that promote better health outcomes and overall well-being, which will lead to the […]
Read more

Neuralink ignites corporate interest in brain-machine interfaces, observes GlobalData

Elon Musk’s update on Neuralink’s successful brain chip implant recently has once again brought the spotlight on the growing interest in brain-machine interface (BMI) research among corporates. Though still in its nascent stages, as indicated by patent publication trends, there has been a consistent rise in innovative activities for universities and start-ups. The surge has […]
Read more

India’s interim defense budget signals focus on modernization to align with evolving geopolitical landscape, says GlobalData

Following the news that Indian Finance Minister Nirmala Sitharaman presented the interim budget ahead of the general elections to be held later this year; Rouble Sharma, Defense Analyst at GlobalData, offers her view: “India has unveiled an interim budget, which is strategically aimed at sustaining essential operations until a comprehensive budget can be presented. The […]
Read more

Asia foodservice landscape transforms with growing adoption of AI, says GlobalData

Technology is fast emerging as a crucial tool for the ever-changing foodservice landscape in Asia by seamlessly transforming the dining experience of customers into a futuristic affair. Players in the foodservice sector, especially quick-service restaurants (QSR), are deploying innovative artificial intelligence (AI) tools to enhance customer experiences as well as improve operational efficiencies to boost […]
Read more

BrainStorm Cell Therapeutics signals continued hope for NurOwn by securing patents, says GlobalData

BrainStorm Cell Therapeutics is still navigating a three-year regulatory journey for the NurOwn therapy that was initiated in February 2021, marked by the FDA’s initial discouragement of filing a Biologics License Application (BLA). However, the recent acquisition of three new patents for NurOwn and NurOwn-Exosomes remains a safeguard for NurOwn’s cell therapy, fostering hope for […]
Read more

South Korea likely to focus on diversifying defense exports in Europe to offset volatility in Polish orders, says GlobalData

The recent change of leadership in Poland will compel Seoul to engage freshly with the new administration to ensure the continuity of its defense exports to Poland. The political change in Poland casts a shadow on the continuity of a portion of defense orders. To mitigate risks that could arise from losing a significant portion […]
Read more

Asia will continue to dominate global refinery alkylation capacity additions through 2028, says GlobalData

Asia is set to witness the highest refinery alkylation capacity additions among all the regions between 2024 and 2028, contributing about 48% of the total global capacity additions by 2028, says GlobalData, a leading data and analytics company. GlobalData’s latest report, “Refinery Alkylation Units Capacity and Capital Expenditure Outlook and Forecast with Details of All […]
Read more

Drug price controls and emphasis on preventive care top solutions to address healthcare inflation, says GlobalData

Inflation in healthcare refers to the persistent increase in the cost of medical goods and services over time. This phenomenon is driven by a combination of factors, including advancements in medical technology, rising labor costs, pharmaceutical innovations, and the complex interplay of supply and demand within the healthcare market. While there are several options for […]
Read more

Boston Scientific may soon end Medtronic’s brief monopoly in pulsed-field ablation space, says GlobalData

In December 2023, Medtronic received FDA approval for its pulsed-field ablation (PFA) system, PulseSelect. While the PulseSelect is not the first PFA system to be marketed in the world (Boston Scientific’s Farapulse system received CE approval in 2021), it is indeed the first PFA catheter system to receive FDA approval. However, Medtronic’s success in this […]
Read more
1 … 87 88 89 90 91 … 136